Matches in Nanopublications for { ?s ?p "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP780221.RAZYtWYb0zhceyTAnTUdw702VHpG_WD_CFTgrKwjEQbTw130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780221.RAZYtWYb0zhceyTAnTUdw702VHpG_WD_CFTgrKwjEQbTw130_provenance.
- assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614247.RAQSW4_RH7M4X8yl70KiSpF_JGOj_zD2guGUNbBR7bv0A130_provenance.
- NP108226.RAngEgEIJGnHdzWrg-M2-QNFr2VkDqJn3rB4mPC4Fb_Jg130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108226.RAngEgEIJGnHdzWrg-M2-QNFr2VkDqJn3rB4mPC4Fb_Jg130_provenance.
- NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536727.RA76ARRIDFBCfvPQndm5GUxaKxh5yeFjm8RoL-thIWY3g130_provenance.
- NP614246.RAy6iqyk9g8h_xxTr9RAjIHysYt3x2Mr9ofg5hiZkHfg4130_assertion description "[Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614246.RAy6iqyk9g8h_xxTr9RAjIHysYt3x2Mr9ofg5hiZkHfg4130_provenance.